Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease
| Status: | Completed |
|---|---|
| Conditions: | Parkinsons Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/18/2017 |
| Start Date: | February 2013 |
| End Date: | May 2017 |
Effect of Osteopathic Manipulative Medicine on Pulmonary Function and Speech in Parkinson's Disease
The purpose of this study is to investigate the effect of selected Osteopathic Manipulative
Medicine (OMM) techniques on the respiratory system of people with Parkinson's Disease (PD)
in comparison to light touch. Effectiveness will be measured through pulmonary function
tests, chest wall expansion, and voice analysis. Selected subjects will be randomly assigned
to one of the two groups: OMM treatment group or light touch group. Although OMM treatment
has been used on PD patients, a randomized controlled study has not been done to establish
its effect on PD respiratory function. The authors believe that this study will show OMM's
effectiveness.
Medicine (OMM) techniques on the respiratory system of people with Parkinson's Disease (PD)
in comparison to light touch. Effectiveness will be measured through pulmonary function
tests, chest wall expansion, and voice analysis. Selected subjects will be randomly assigned
to one of the two groups: OMM treatment group or light touch group. Although OMM treatment
has been used on PD patients, a randomized controlled study has not been done to establish
its effect on PD respiratory function. The authors believe that this study will show OMM's
effectiveness.
Osteopathic Manipulative Medicine (OMM) on the thoracic cage and diaphragm is commonly used
in clinical practice to address myofascial imbalances, including muscle spasms to improve
thoracic cage excursion. Prior research has demonstrated that manual approaches applied to
the thoracic cage have positive results with lung function and reducing inflammation.
Parkinson's disease (PD) is a common disabling and progressive neuro-degenerative disorder.
Morbidity and mortality are frequently associated with pulmonary dysfunction in patients with
PD. Pulmonary function tests (PFT) have been utilized to document respiratory impairment in
PD patients. Researchers estimate that 89% of people with PD have speech and voice disorders
including disorders of laryngeal, respiratory and articulatory function.
These authors hypothesize that performing OMM on the thoracic cage of PD subjects will show
improvement in PFT, chest expansion, and speech production. Subjects with PD meeting the
criteria for the study will be randomly assigned to either an OMM treatment or light touch
control group. Each subject will be involved in one treatment visit. During this visit, the
following will be measured before and after OMM or light touch procedures: maximal and
minimal chest circumference; sound pressure, duration, and perceptual measures during
sustained vowel phonation and Rainbow Reading; Forced Vital Capacity (FVC), Forced Expiratory
Volume/1 second (FEV1), Peak Expiratory Flow (PEF), Forced Expiratory Flow 25%-75%
(FEF25-75%), and Maximal Voluntary Ventilation (MVV). Data analysis will be performed with
SPSS using Analysis of Covariance to measure significance.
in clinical practice to address myofascial imbalances, including muscle spasms to improve
thoracic cage excursion. Prior research has demonstrated that manual approaches applied to
the thoracic cage have positive results with lung function and reducing inflammation.
Parkinson's disease (PD) is a common disabling and progressive neuro-degenerative disorder.
Morbidity and mortality are frequently associated with pulmonary dysfunction in patients with
PD. Pulmonary function tests (PFT) have been utilized to document respiratory impairment in
PD patients. Researchers estimate that 89% of people with PD have speech and voice disorders
including disorders of laryngeal, respiratory and articulatory function.
These authors hypothesize that performing OMM on the thoracic cage of PD subjects will show
improvement in PFT, chest expansion, and speech production. Subjects with PD meeting the
criteria for the study will be randomly assigned to either an OMM treatment or light touch
control group. Each subject will be involved in one treatment visit. During this visit, the
following will be measured before and after OMM or light touch procedures: maximal and
minimal chest circumference; sound pressure, duration, and perceptual measures during
sustained vowel phonation and Rainbow Reading; Forced Vital Capacity (FVC), Forced Expiratory
Volume/1 second (FEV1), Peak Expiratory Flow (PEF), Forced Expiratory Flow 25%-75%
(FEF25-75%), and Maximal Voluntary Ventilation (MVV). Data analysis will be performed with
SPSS using Analysis of Covariance to measure significance.
Inclusion Criteria:
- Medically diagnosed with Parkinson's Disease
- on a stable medication dose
- over the age of 18
Exclusion Criteria:
- no clinical diagnosis of Parkinson's Disease
- - medication that might cause pulmonary dysfunction
- inability to perform PFT because of anatomical abnormalities
- clinical signs of dementia
- pacemaker that interferes with pectoral traction
- metastatic cancer
We found this trial at
1
site
Click here to add this to my saved trials
